Protocol Development and Quality Improvement

added without interventions and cost savings metrics

associated with it (Answer c is incorrect). While renal

dose adjustments and intravenous to oral conversion are

interventions clinical pharmacists frequently make, they

do not provide measurable metrics unless associated

with a cost savings and safety benefit (Answer D is

incorrect).

Answer: C

Answer A is incorrect because it solely focuses on cost

with little rationale on how this might impact the patient

clinically. Answer B is incorrect because it is worded

such that it is implying harm will result if the provider

does not take the recommendation. Answer C is correct

because it is worded that the provider should consider

the recommendation as well as the rationale as to why.

Answer D is incorrect because it is focusing on the fact

that it is non-formulary and would likely cause harm if

the provider does not take the recommendation.